News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,340 Results
Type
Article (8017)
Company Profile (139)
Press Release (475088)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166796)
Career Advice (306)
Deals (25743)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9763)
Job Trends (8578)
News (238276)
Policy (17930)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (483)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33166)
ALS (102)
Alzheimer's disease (966)
Antibody-drug conjugate (ADC) (254)
Approvals (10343)
Artificial intelligence (310)
ASCO (159)
Autoimmune disease (196)
Automation (28)
Bankruptcy (262)
Best Places to Work (6964)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (501)
Cancer (3563)
Cardiovascular disease (214)
Career advice (246)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47740)
Collaboration (1206)
Commercialization (1)
Compensation (1390)
Complete response letters (33)
COVID-19 (751)
CRISPR (62)
C-suite (707)
Cystic fibrosis (84)
Data (5509)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (336)
Diagnostics (4152)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (145)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (158)
Earnings (73074)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87478)
Executive appointments (681)
FDA (12296)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (894)
Gene editing (123)
Generative AI (9)
Gene therapy (309)
GLP-1 (284)
Government (949)
Grass and pollen (2)
Guidances (280)
Healthcare (9320)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (96)
Immuno-oncology (54)
Indications (151)
Infectious disease (937)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (42)
IPO (12381)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Liver cancer (43)
Longevity (15)
Lung cancer (490)
Lymphoma (242)
Machine learning (27)
Management (3)
Manufacturing (511)
Marketing (7)
MASH (116)
Medical device (8645)
Medtech (8768)
Mergers & acquisitions (14354)
Metabolic disorders (690)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1786)
NextGen: Class of 2026 (3153)
Non-profit (845)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (11)
Patents (457)
Patient recruitment (477)
Peanut (31)
People (41142)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15429)
Phase 2 (21316)
Phase 3 (14355)
Pipeline (6664)
Policy (18)
Postmarket research (1572)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (557)
Real estate (3022)
Recruiting (6)
Regulatory (14697)
Reports (16)
Research institute (579)
Resumes & cover letters (46)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (98)
Series A (149)
Series B (117)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (49)
Vaccines (311)
Venture capital (17)
Weight loss (70)
Women's health (75)
Date
Last 7 days (261)
Last 30 days (1068)
Last 365 days (19044)
2026 (10766)
2025 (19269)
2024 (23000)
2023 (26556)
2022 (34601)
2021 (37190)
2020 (33490)
2019 (23284)
2018 (17468)
2017 (18770)
2016 (17920)
2015 (24264)
2014 (21686)
2013 (18135)
2012 (20222)
2011 (20442)
2010 (20336)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (292)
Arkansas (11)
Asia (17844)
Australia (2090)
California (11522)
Canada (3043)
China (506)
Colorado (464)
Connecticut (390)
Delaware (203)
Europe (24574)
Florida (1716)
Georgia (364)
Hawaii (2)
Idaho (46)
Illinois (679)
India (42)
Indiana (308)
Iowa (13)
Japan (386)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1154)
Massachusetts (7586)
Michigan (299)
Minnesota (539)
Mississippi (4)
Missouri (110)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2536)
New Mexico (12)
New York (2736)
North Carolina (1228)
North Dakota (4)
Northern California (5735)
Ohio (268)
Oklahoma (14)
Oregon (14)
Pennsylvania (2192)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4780)
Tennessee (113)
Texas (1858)
United States (37527)
Utah (345)
Vermont (1)
Virginia (146)
Washington D.C. (38)
Washington State (893)
West Virginia (1)
Wisconsin (73)
483,340 Results for "stereotaxis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stereotaxis Completes Acquisition of Robocath
July 9, 2026
·
5 min read
Press Releases
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
July 21, 2026
·
1 min read
Press Releases
Stereotaxis Announces Definitive Agreement to Acquire Robocath
April 15, 2026
·
9 min read
Press Releases
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
May 13, 2026
·
9 min read
Press Releases
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
April 6, 2026
·
5 min read
Press Releases
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
April 21, 2026
·
1 min read
Press Releases
Stereotaxis Reports 2025 Full Year Financial Results
March 9, 2026
·
10 min read
Press Releases
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
January 6, 2026
·
4 min read
Press Releases
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026
February 12, 2026
·
1 min read
Press Releases
Stereotaxis Reports 2025 Third Quarter Financial Results
November 11, 2025
·
9 min read
1 of 48,334
Next
